Soni Manmeet Singh
COO and CFO
Soni Manmeet Singh has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jun 4, 2026.
On the most recent filing, Soni Manmeet Singh is listed as COO and CFO at Summit Therapeutics Inc. Inside the rolling window, Soni Manmeet Singh reported 1 open-market purchase totaling $722K in SMMT and no open-market sales.
Companies traded
Other insiders at SMMT
Insider Buying
$722K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Soni Manmeet Singh made?
Soni Manmeet Singh has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Soni Manmeet Singh trade?
Soni Manmeet Singh has filed SEC Form 4 disclosures for 1 company, including SMMT.
When was Soni Manmeet Singh's most recent SEC Form 4 filing?
Soni Manmeet Singh's most recent SEC Form 4 filing on Tracefour is dated Jun 4, 2026.
What is Soni Manmeet Singh's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Soni Manmeet Singh is listed as COO and CFO.
What is Soni Manmeet Singh's total buy and sell value in the current window?
Inside the rolling retention window, Soni Manmeet Singh bought $722K and sold $0 based on SEC Form 4 filings.
What was Soni Manmeet Singh's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 50,000 SMMT shares on 2026-06-04, worth $722K, per SEC Form 4 filings.